DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 170 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $364,000 | -5.2% | 10,713 | +2.2% | 0.01% | 0.0% |
Q2 2021 | $384,000 | -15.2% | 10,480 | +3.7% | 0.01% | -20.0% |
Q1 2021 | $453,000 | -24.5% | 10,106 | -3.9% | 0.01% | -16.7% |
Q4 2020 | $600,000 | +4.0% | 10,519 | -6.5% | 0.01% | -20.0% |
Q3 2020 | $577,000 | +83.2% | 11,249 | +113.5% | 0.02% | +66.7% |
Q2 2020 | $315,000 | +19.3% | 5,268 | -17.8% | 0.01% | -10.0% |
Q1 2020 | $264,000 | -83.6% | 6,410 | -92.5% | 0.01% | -83.3% |
Q3 2017 | $1,614,000 | – | 85,000 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 1,209,571 | $69,030,000 | 15.95% |
SV Health Investors, LLC | 449,951 | $25,679,000 | 12.37% |
Sunesis Advisors, LLC | 96,299 | $5,496,000 | 4.45% |
Redmile Group, LLC | 4,437,968 | $253,275,000 | 3.07% |
Consonance Capital Management LP | 484,671 | $27,660,000 | 2.58% |
SECTORAL ASSET MANAGEMENT INC | 488,842 | $27,898,000 | 1.97% |
Opaleye Management Inc. | 222,000 | $12,670,000 | 1.66% |
Eversept Partners, LP | 246,240 | $14,052,917 | 1.65% |
SILVERARC CAPITAL MANAGEMENT, LLC | 38,620 | $2,204,000 | 1.28% |
Avoro Capital Advisors LLC | 1,300,000 | $74,191,000 | 1.28% |